ADMA - ADMA BIOLOGICS, INC.
16.38
-0.200 -1.221%
Share volume: 3,109,998
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$16.58
-0.20
-0.01%
Summary score
66%
Profitability
81%
Dept financing
26%
Liquidity
75%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
3.84%
Return on sales
12.17%
Return on invested capital
0%
Total debt ratio
46.99%
Debt ratio change over timeo
0%
Current Ratio
6.47%
Quick Ratio
2.74%
Cash Position Ratio
1.55%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
8.37%
Return on sales
37.14%
Return on invested capital
0%
Total debt ratio
25.81%
Debt ratio change over timeo
0%
Current Ratio
6.44%
Quick Ratio
3.38%
Cash Position Ratio
1.22%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
10.05%
Return on sales
45.09%
Return on invested capital
0%
Total debt ratio
23.54%
Debt ratio change over time
0%
Current Ratio
6.71%
Quick Ratio
3.74%
Cash Position Ratio
1.26%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADMA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | 3.84% | 2.97% | 3.34% | 2.04% |
| Return on sales | 12.17% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 36% | 44% | 72% | 83% |
| Total debt ratio | 46.99% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | 0% | 14.34% | 187.33% | 9.75% |
| Dept financing | 13% | 27% | 43% | 13% |
| Current Ratio | 6.44% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 3.38% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.22% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 31% | 25% | 36% |
| Short-term ratios | ADMA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 8.37% | 3.27% | 4.7% | 1.36% |
| Return on sales | 37.14% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 100% | 26% | 37% | 14% |
| Total debt ratio | 25.81% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 25% | 18% | 10% |
| Current Ratio | 6.44% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 3.38% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.22% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 20% | 27% | 39% |